Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide: A case report.

Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide: A case report. — المؤلف: Burgos, Sebastian — Medicine 20190116

المؤلف
Burgos, Sebastian
النشر
Medicine 20190116
الوصف
e14011 p.
الموضوعات
Aged؛ Anemia؛ Angiogenesis Inhibitors؛ Antineoplastic Agents, Alkylating؛ Antineoplastic Agents, Hormonal؛ B-Lymphocytes؛ Bone Marrow؛ Chromosome Deletion